• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用传统培养和新一代测序技术研究营养习惯、体重指数和肥大细胞增多症中的肠道微生物群对临床症状的影响。

The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing.

作者信息

Harcęko-Zielińska Ewelina, Niedoszytko Marek, Górska Aleksandra, Małgorzewicz Sylwia, Gruchała-Niedoszytko Marta, Bronk Marek, Dąbrowski Slawomir, Chełminska Marta, Jassem Ewa

机构信息

Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland.

Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland.

出版信息

Clin Transl Allergy. 2024 Jan;14(1):e12310. doi: 10.1002/clt2.12310.

DOI:10.1002/clt2.12310
PMID:38282197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10787583/
Abstract

BACKGROUND

Mastocytosis is a rare neoplastic disease of the bone marrow associated with the proliferation and accumulation of mast cells in various internal organs, including the gastrointestinal tract. There are few studies describing the gut microbiome of patients with mastocytosis using next generation sequencing supported using traditional culture methods. The aims of the study were, firstly, the determination of nutrition habits, composition of the intestinal microflora and BMI in mastocytosis, and secondly, analysis of mastocytosis severity and symptoms depending on the composition of the intestinal microflora.

METHODS

The study included 47 patients with indolent systemic mastocytosis and 18 healthy controls. All participants gave their informed consent to participate in the study. The study consisted of 3 parts: I-clinical assessment, II - examination of the intestinal microflora using the biochemical method, III - 16S rRNA sequencing.

RESULTS

The nutrition habits and BMI of mastocytosis patients were similar to controls; however, most patients with mastocytosis had a low dietary vitamin and mineral content. As many as 94.5% of patients had too little fiber intake and mineral content. The most common cause of the abnormal stool test result with traditional culture was a titer of E. coli <10 . The low richness of microbiota species indicated by the Simpson index was observed in mastocytosis, p = 0.04. There were no significant differences in the composition of the intestinal microflora depending on the type of mastocytosis; however, the tryptase level correlated with the amount of Suterella, Barnesiellaceae, Eubacterium, Odoribacter, and Anaerostipes.

CONCLUSIONS

The nutritional habits and BMI of mastocytosis patients are similar to the general population, except for too little fiber intake and mineral content. The gastrointestinal symptoms of mastocytosis patients may be related to the low richness of microbiota species and the amount of Suterella, Barnesiellaceae, Eubacterium, Odoribacter, Anaerostipes, which correlated with tryptase levels.

摘要

背景

肥大细胞增多症是一种罕见的骨髓肿瘤性疾病,与肥大细胞在包括胃肠道在内的各种内脏器官中的增殖和积聚有关。很少有研究使用下一代测序并结合传统培养方法来描述肥大细胞增多症患者的肠道微生物群。本研究的目的,一是确定肥大细胞增多症患者的营养习惯、肠道微生物群组成和体重指数(BMI),二是根据肠道微生物群组成分析肥大细胞增多症的严重程度和症状。

方法

本研究纳入了47例惰性系统性肥大细胞增多症患者和18名健康对照者。所有参与者均签署了参与本研究的知情同意书。本研究包括3个部分:I - 临床评估;II - 使用生化方法检查肠道微生物群;III - 16S rRNA测序。

结果

肥大细胞增多症患者的营养习惯和BMI与对照组相似;然而,大多数肥大细胞增多症患者的饮食中维生素和矿物质含量较低。多达94.5%的患者纤维摄入量和矿物质含量过少。传统培养法粪便检测结果异常最常见的原因是大肠杆菌滴度<10 。肥大细胞增多症患者中观察到辛普森指数所表明的微生物物种丰富度较低,p = 0.04。根据肥大细胞增多症的类型,肠道微生物群组成没有显著差异;然而,类胰蛋白酶水平与萨特氏菌属、巴内西氏菌科、真杆菌属、气味杆菌属和厌氧棒菌属的数量相关。

结论

肥大细胞增多症患者的营养习惯和BMI与一般人群相似,只是纤维摄入量和矿物质含量过少。肥大细胞增多症患者的胃肠道症状可能与微生物物种丰富度较低以及与类胰蛋白酶水平相关的萨特氏菌属、巴内西氏菌科、真杆菌属、气味杆菌属、厌氧棒菌属的数量有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/636626773ba6/CLT2-14-e12310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/a2524d13f003/CLT2-14-e12310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/42b69a3db880/CLT2-14-e12310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/0be6adc5b866/CLT2-14-e12310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/636626773ba6/CLT2-14-e12310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/a2524d13f003/CLT2-14-e12310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/42b69a3db880/CLT2-14-e12310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/0be6adc5b866/CLT2-14-e12310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb51/10787583/636626773ba6/CLT2-14-e12310-g004.jpg

相似文献

1
The influence of nutritional habits, body mass index and intestinal microbiota in mastocytosis on clinical symptoms using conventional culture and next generation sequencing.采用传统培养和新一代测序技术研究营养习惯、体重指数和肥大细胞增多症中的肠道微生物群对临床症状的影响。
Clin Transl Allergy. 2024 Jan;14(1):e12310. doi: 10.1002/clt2.12310.
2
Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.骨髓血中类胰蛋白酶检测:系统性肥大细胞增多症的一种新诊断工具。
J Am Acad Dermatol. 2007 Mar;56(3):453-7. doi: 10.1016/j.jaad.2006.09.020. Epub 2006 Oct 30.
3
Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.小儿肥大细胞增多症管理中临床发现、类胰蛋白酶水平及骨髓组织病理学评估
J Allergy Clin Immunol. 2015 Dec;136(6):1673-1679.e3. doi: 10.1016/j.jaci.2015.04.024. Epub 2015 Jun 1.
4
Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.血清白细胞介素-6反映肥大细胞增多症患者的疾病严重程度和骨质疏松情况。
Int Arch Allergy Immunol. 2002 Aug;128(4):344-50. doi: 10.1159/000063858.
5
Diagnostic criteria and classification of mastocytosis: a consensus proposal.肥大细胞增多症的诊断标准与分类:一项共识提议。
Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8.
6
A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.24 例累及胃肠道的系统性肥大细胞增多症的临床病理研究及肠易激综合征和无症状患者的黏膜肥大细胞密度评估。
Am J Surg Pathol. 2014 Jun;38(6):832-43. doi: 10.1097/PAS.0000000000000190.
7
Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.在超重的老年人群中,类胰蛋白酶的可靠性降低可作为肥大细胞增多症的风险指标。
J Allergy Clin Immunol. 2015 Mar;135(3):792-8. doi: 10.1016/j.jaci.2014.05.047. Epub 2014 Aug 13.
8
Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.色素性荨麻疹演变为惰性系统性肥大细胞增多症:肥大细胞免疫表型异常,无c-kit突变ASP-816-VAL证据
Leuk Lymphoma. 2003 Feb;44(2):313-9. doi: 10.1080/1042819021000037967.
9
Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.成人肥大细胞增多症:圣安东尼奥医院的经验回顾及对世界卫生组织系统性疾病诊断标准的评估
An Bras Dermatol. 2014 Jan-Feb;89(1):59-66. doi: 10.1590/abd1806-4841.20141847.
10
Skin and bones: systemic mastocytosis and bone.皮包骨头:系统性肥大细胞增多症与骨骼
Endocrinol Diabetes Metab Case Rep. 2023 May 11;2023(2). doi: 10.1530/EDM-22-0408. Print 2023 May 1.

本文引用的文献

1
: A Beneficial Gut Organism From the Discoveries in Genus and Species.有益肠道生物的发现源于属和种的研究。
Front Cell Infect Microbiol. 2021 Nov 22;11:757718. doi: 10.3389/fcimb.2021.757718. eCollection 2021.
2
Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome.益生菌辅助治疗通过调节肠道微生物组和血清代谢组缓解哮喘症状。
Microbiol Spectr. 2021 Oct 31;9(2):e0085921. doi: 10.1128/Spectrum.00859-21. Epub 2021 Oct 6.
3
Gut Microbiota, in the Halfway between Nutrition and Lung Function.
肠道微生物群,在营养与肺功能之间的半路上。
Nutrients. 2021 May 19;13(5):1716. doi: 10.3390/nu13051716.
4
Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis.肥大细胞增多症中IgE介导的食物超敏反应发生率低。
J Allergy Clin Immunol Pract. 2020 Oct;8(9):3093-3101. doi: 10.1016/j.jaip.2020.05.044. Epub 2020 Jun 10.
5
Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.肥大细胞类胰蛋白酶促进炎症性肠病诱导的肠道纤维化。
Inflamm Bowel Dis. 2021 Jan 19;27(2):242-255. doi: 10.1093/ibd/izaa125.
6
Short-chain fatty acids modulate mast cell activation.短链脂肪酸调节肥大细胞活化。
Allergy. 2020 Aug;75(8):1848-1849. doi: 10.1111/all.14313.
7
A metagenome-wide association study of gut microbiota in asthma in UK adults.一项针对英国成年人哮喘肠道微生物组的宏基因组关联研究。
BMC Microbiol. 2018 Sep 12;18(1):114. doi: 10.1186/s12866-018-1257-x.
8
Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases.膳食纤维及其代谢产物对肥大细胞活化及肥大细胞相关性疾病的影响
Front Immunol. 2018 May 29;9:1067. doi: 10.3389/fimmu.2018.01067. eCollection 2018.
9
Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.丁酸盐对 2 型固有淋巴细胞依赖性气道高反应性的调节作用。
J Allergy Clin Immunol. 2018 Dec;142(6):1867-1883.e12. doi: 10.1016/j.jaci.2018.02.032. Epub 2018 Mar 6.
10
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.普拉梭菌:从微生物学至诊断与预后评估
ISME J. 2017 Apr;11(4):841-852. doi: 10.1038/ismej.2016.176. Epub 2017 Jan 3.